Status:
COMPLETED
Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy
Lead Sponsor:
University Hospital, Geneva
Conditions:
Iron Induced Hypophosphatemia
Eligibility:
FEMALE
Brief Summary
Iron deficiency anemia (IDA) is a very common health problem during pregnancy and intravenous (IV) iron substitution has become part of routine management. Recent studies have raised concerns about as...
Eligibility Criteria
Inclusion
- Single pregnancy
- Term (\>37SA) pregnancy
- Oral or IV iron substitution from second trimester
Exclusion
- Multiple pregnancy
- Fetal anomalies
- Preterm birth
Key Trial Info
Start Date :
September 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 3 2023
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT06108258
Start Date
September 23 2022
End Date
March 3 2023
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland